Epocrates Helped Physicians Avoid 27 Million Drug Errors In 2012
The majority of U.S. physicians currently use a mobile device, such as a smartphone, tablet or combination of both, to access Epocrates. Most physicians who use the app access it daily, primarily during patient encounters. Epocrates products are available on popular platforms such as Apple iOS and Google Android OS. For more information and to download the app, visit www.epocrates.com/mobile .
About Epocrates, Inc.
Epocrates, Inc. (Nasdaq:EPOC) is recognized for developing the #1 medical application among U.S. physicians for clinical content, practice tools and health industry engagement at the point of care. Epocrates has established a loyal network of more than one million healthcare professionals, including 50 percent of U.S. physicians, who routinely use its intuitive solutions to help streamline workflow and improve patient care. The company also facilitates the delivery of valuable content and tools between partnering organizations and its members. For more information, please visit www.epocrates.com/company .
The Epocrates, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10943Epocrates is a trademark of Epocrates, Inc., registered in the U.S. and other countries. 1 2012 Epocrates Specialty Survey (n= 2,700 U.S. physicians). Results are available at: http://www.epocrates.com/who/media/mediaresources/statistics .
CONTACT: Erica Sniad Morgenstern Senior Director, Public Relations and Communications Epocrates, Inc. (650) 227-6907 email@example.com
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV